THE success of chronic hemodialysis in terminal renal failure depends on repeated access to blood vessels that will provide a continuous flow of up to 250 to 300 ml. per minute. A technic was ...

Vascular access dysfunction is a major cause of morbidity and hospitalization in dialysis patients. Arteriovenous fistulas (AVFs) are considered the gold standard of vascular access for dialysis.

Xeltis has developed aXess to improve on infection and reintervention rates compared to other dialysis access approaches.

Background: Arteriovenous fistula (AVF) remains the preferred method of vascular access in patients requiring long-term maintenance hemodialysis for end stage renal disease (ESRD). However, the AVF ...

vascular access outcomes than an autologous arteriovenous fistula (AVF), according to phase 3 trial data presented at the American Society of Nephrology’s 2024 Kidney Week conference in San ...

She had recurrent haematuria so her CT was reviewed with the radiologist with clinical suspicion of arteriovenous malformation (AVM) which was suggested by relatively increased contrast density in the ...

A portion of the proceeds will support the ongoing evidence development for EchoMark and EchoSure, including the MAFASA trial ...

other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistula, and arterial and venous embolizations in the peripheral vasculature Penumbra, Inc. (Peripheral Vascular ...

Vascular complications that occur later include renal artery stenosis, intrarenal pseudoaneurysm, and arteriovenous fistula. Renal artery thrombosis is an early (within the first 2 days ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...